Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Colorectal Neoplasms × Radiofrequency Ablation × Clear all

Phase

Phase 2 5 Phase 4 2 Phase NA 1 Phase 3 1 Phase 2/3 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 2 Melanoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Advanced Malignant Solid Tumor 1

Interventions

Fluorouracil 59 pembrolizumab 52 Cetuximab 51 Oxaliplatin 49 Bevacizumab 49 Irinotecan 48 Leucovorin 47 Capecitabine 25 Nivolumab 19 Gemcitabine 16 Cisplatin 16 IFL protocol 15 Folfox protocol 15 Carboplatin 15 atezolizumab 14 Specimen Handling 14 Paclitaxel 14 Cyclophosphamide 14 Biopsy 13 Magnetic Resonance Spectroscopy 12 trifluridine tipiracil drug combination 11 Pemetrexed 10 spartalizumab 9 regorafenib 9 trametinib 8 130-nm albumin-bound paclitaxel 8 fludarabine 7 durvalumab 7 Trifluridine 7 dehydroftorafur 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04062721 2025-04-06

LICoRN-01

Assistance Publique - Hôpitaux de Paris

Phase 1 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡